Literature DB >> 22065058

Transurethral prostate biopsy before radical cystectomy remains clinically relevant for decision-making on urethrectomy in patients with bladder cancer.

Koji Ichihara1, Hiroshi Kitamura, Naoya Masumori, Fumimasa Fukuta, Taiji Tsukamoto.   

Abstract

BACKGROUND: This study retrospectively evaluated the clinical relevance of transurethral prostate biopsy (TUPB) before radical cystectomy by comparing the pathology of prostatic urethra biopsy specimens with that of cystectomy specimens.
METHODS: Of 294 patients who underwent cystectomy and urinary diversion, 101 men with preoperative TUPB were included in this study. For these patients, if the result of TUPB was positive for urothelial carcinoma, we performed urethrectomy as a rule. If it was negative, we presented the option of urethral preservation and decided the final type of urinary reconstruction. The sensitivity, specificity, and positive and negative predictive values (PPV and NPV) of TUPB were assessed, and we investigated the number of final urethral recurrences. We also tried to identify which clinical and pathological findings by TUPB most accurately predicted the disease remaining in the prostate of cystectomy specimens.
RESULTS: Of the 25 patients with positive TUPB, 18 had disease in the prostatic urethra or stroma of cystectomy specimens. There were 3 patients with negative TUPB but with involvement of the prostate in cystectomy specimens. Thus, TUPB achieved 86% sensitivity, 91% specificity, 72% PPV, and 96% NPV. Two patients (1.9%) had urethral recurrence in this period. Among the findings for TUPB, non-papillary tumors most accurately predicted the disease in the prostate of cystectomy specimens.
CONCLUSIONS: TUPB achieved a high NPV and the urethral recurrence rate was acceptable. If TUPB was negative, patients could have chance urethral preservation. Thus, our clinical decision for urethrectomy based on the result of TUPB is still useful.

Entities:  

Mesh:

Year:  2011        PMID: 22065058     DOI: 10.1007/s10147-011-0346-8

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  23 in total

1.  Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomy.

Authors:  J H Reese; F S Freiha; A B Gelb; B L Lum; F M Torti
Journal:  J Urol       Date:  1992-01       Impact factor: 7.450

2.  Involvement of the anterior urethra in male patients with transitional cell-carcinoma of the bladder undergoing radical cystectomy with simultaneous urethrectomy.

Authors:  K Tobisu; Y Kanai; M Sakamoto; H Fujimoto; N Doi; S Horie; T Kakizoe
Journal:  Jpn J Clin Oncol       Date:  1997-12       Impact factor: 3.019

3.  Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome.

Authors:  H W Herr; S M Donat
Journal:  J Urol       Date:  1999-06       Impact factor: 7.450

Review 4.  Transitional cell carcinoma of the urethra in men and women associated with bladder cancer.

Authors:  T Kakizoe; K Tobisu
Journal:  Jpn J Clin Oncol       Date:  1998-06       Impact factor: 3.019

5.  Urethral recurrence of transitional cell carcinoma of the bladder. Predictive value of preoperative latero-montanal biopsies and urethral frozen sections during prostatocystectomy.

Authors:  T Lebret; J M Hervé; P Barré; F Gaudez; P M Lugagne; M Barbagelatta; H Botto
Journal:  Eur Urol       Date:  1998       Impact factor: 20.096

6.  Urethral recurrence in patients with orthotopic ileal neobladders.

Authors:  J A Freeman; T A Tarter; D Esrig; J P Stein; D A Elmajian; S C Chen; S Groshen; G Lieskovsky; D G Skinner
Journal:  J Urol       Date:  1996-11       Impact factor: 7.450

7.  Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.

Authors:  D Esrig; J A Freeman; D A Elmajian; J P Stein; S C Chen; S Groshen; A Simoneau; E C Skinner; G Lieskovsky; S D Boyd; R J Cote; D G Skinner
Journal:  J Urol       Date:  1996-09       Impact factor: 7.450

8.  Prostatic urethral biopsy has limited usefulness in counseling patients regarding final urethral margin status during orthotopic neobladder reconstruction.

Authors:  Wassim Kassouf; Philippe E Spiess; Gordon A Brown; Ping Liu; H Barton Grossman; Colin P N Dinney; Ashish M Kamat
Journal:  J Urol       Date:  2008-05-15       Impact factor: 7.450

9.  Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancer.

Authors:  Roberta Mazzucchelli; Francesca Barbisan; Alfredo Santinelli; Marina Scarpelli; Andrea B Galosi; Antonio Lopez-Beltran; Liang Cheng; Ziya Kirkali; Rodolfo Montironi
Journal:  Urology       Date:  2009-06-07       Impact factor: 2.649

10.  Importance of early treatment of transitional cell carcinoma of prostatic ducts.

Authors:  K I Wishnow; J Y Ro
Journal:  Urology       Date:  1988-07       Impact factor: 2.649

View more
  2 in total

1.  Risk factors, follow-up, and treatment of urethral recurrence following radical cystectomy and urinary diversion for bladder cancer: a meta-analysis of 9498 patients.

Authors:  Xinyuan Li; Wuwan Wang; Gongmin Zhu; Weiyang He; Xin Gou
Journal:  Oncotarget       Date:  2017-12-19

2.  Prostatic urethra recurrence after transurethral resection of bladder tumor (TURBT) for non-muscle-invasive bladder cancer (NMIBC).

Authors:  Vladimir Bilim; Senji Hoshi
Journal:  Clin Case Rep       Date:  2022-01-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.